Search Press releases Keywords From To 2 May 2022 JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA[®]▼(fenfluramine) Oral Solution for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) Read More 28 Apr 2022 UCB’s General Meeting of Shareholders 2022 Read More 22 Apr 2022 Disposal of own shares Read More 15 Apr 2022 Disposal of own shares Read More 11 Apr 2022 Disposal of own shares Read More 1 Apr 2022 Disposal of own shares Read More Pagination First page Previous page Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Page 35 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
